705 related articles for article (PubMed ID: 15949731)
1. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
2. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
Carlsen J; Johansen M; Boesgaard S; Andersen CB; Arendrup H; Aldershvilet J; Mortensen SA
J Heart Lung Transplant; 2005 Mar; 24(3):296-302. PubMed ID: 15737756
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring.
Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D
Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170
[TBL] [Abstract][Full Text] [Related]
4. [Low-dose antithymocyte globulins in kidney transplantation: results of a protocol of intermittent administration].
Mourad G; Portales P; Garrigue V; Djamali A; Bouloux C; Chong G; Clot J
Nephrologie; 2000; 21(5):253-8. PubMed ID: 11068775
[TBL] [Abstract][Full Text] [Related]
5. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
Wieneke H; Otte B; Lang D; Heidenreich S
Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
[TBL] [Abstract][Full Text] [Related]
7. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients.
Schnetzler B; Leger P; Völp A; Dorent R; Pavie A; Gandjbakhch I
Transpl Int; 2002 Jun; 15(6):317-25. PubMed ID: 12072903
[TBL] [Abstract][Full Text] [Related]
9. Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients.
Esposito L; Kamar N; Tkaczuk J; Abbal M; Durand D; Rostaing L
Transplant Proc; 2005 Mar; 37(2):785-7. PubMed ID: 15848531
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
11. Short-term versus long-term induction therapy with antithymocyte globulin in orthotopic liver transplantation.
Soliman T; Hetz H; Burghuber C; Györi G; Silberhumer G; Steininger R; Mühlbacher F; Berlakovich GA
Transpl Int; 2007 May; 20(5):447-52. PubMed ID: 17343686
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation.
Mullen JC; Oreopoulos A; Lien DC; Bentley MJ; Modry DL; Stewart K; Winton TL; Jackson K; Doucette K; Preiksaitis J; Halloran PF
J Heart Lung Transplant; 2007 May; 26(5):504-10. PubMed ID: 17449421
[TBL] [Abstract][Full Text] [Related]
13. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
[TBL] [Abstract][Full Text] [Related]
14. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
[TBL] [Abstract][Full Text] [Related]
15. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
[TBL] [Abstract][Full Text] [Related]
16. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
Copeland JG; Icenogle TB; Williams RJ; Rosado LJ; Butman SM; Vasu MA; Sethi GK; McDonald AN; Klees E; Rhenman MJ
J Thorac Cardiovasc Surg; 1990 May; 99(5):852-60. PubMed ID: 2329823
[TBL] [Abstract][Full Text] [Related]
17. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D
Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment of low dose Anti-Thymocyte Globulin (ATG), Rituximab and high dose Sirolimus as induction agents in immune-conditioned recipients.
Ravichandran P; Natrajan T; Jaganathan R
Int Immunopharmacol; 2006 Dec; 6(13-14):1973-6. PubMed ID: 17161350
[TBL] [Abstract][Full Text] [Related]
19. Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation.
Soliman T; Hetz H; Burghuber C; Györi G; Silberhumer G; Steininger R; Mühlbacher F; Berlakovich GA
Liver Transpl; 2007 Jul; 13(7):1039-44. PubMed ID: 17600336
[TBL] [Abstract][Full Text] [Related]
20. Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients.
Wang D; Wu WZ; Yang SL; Chen JH; Tan JM
Chin Med J (Engl); 2006 Oct; 119(20):1683-8. PubMed ID: 17097014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
